Marcus Droege

Marcus Droege is a seasoned biopharmaceutical executive with over 20 years of experience in commercial, medical, and clinical development functions.

He specializes in global market access and pricing, real-world evidence (RWE), health economics and outcomes research (HEOR), medical strategy development, and execution.

Marcus has successfully led multiple global product launches across various therapeutic areas including immunology, hematology, oncology, gastroenterology, cardiometabolics, and neurology.

His expertise extends to strategic project leadership, formulary access, insights and analytics strategy, and payer evidence generation.

Throughout his career, Marcus has maximized the value of medical affairs functions, developed comprehensive late-stage development plans, and optimized product value through all life-cycle stages.

He possesses strong leadership, advocacy, negotiation, and P&L management skills, having managed global commercial operations and medical teams with significant financial responsibilities.

With a solid scientific background, Marcus is a thought leader in health economics and outcomes research with numerous peer-reviewed publications, international presentations, and accolades.

He is known for his ability to optimize systems, processes, and structures, as well as for his expertise in health policy and global innovation access.

Marcus excels in leadership, influencing capabilities, innovation, and navigating complex global organizations.

Additionally, he is multilingual, holds multiple citizenships (USA, EU), and is a licensed pharmacist.

His educational background includes a PhD, MS, and Pharmacy degree from the University of Minnesota-Twin Cities, an MBA in Business from Northeastern University, and a BS in Pharmacy from the University of Münster.

Throughout his career, Marcus has held key roles at renowned organizations like bluebird bio, Novartis Gene Therapies, Celgene, and Takeda, with responsibilities ranging from global head of real-world evidence to director of global knowledge management.

His diverse experience includes leadership positions in knowledge, evidence, value, outcomes research, and clinical science, demonstrating his versatility and expertise across multiple domains within the biopharmaceutical industry.